Drug recall · January 11, 2023
Prochlorperazine Maleate Tablets recall
Why: Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, Maryland 21801, NDC 59746-113-06
- Lots / codes
Lot#: 21P0336, Exp: 04/2023
- Quantity
- 14,061 bottles
- Company
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Distribution
- Nationwide in the USA.
- Initiated
- December 27, 2022 · Voluntary: Firm initiated
- Classified
- January 5, 2023
- Reported
- January 11, 2023
- Ended
- December 5, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Prochlorperazine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.